article thumbnail

Sanofi prevails over Boehringer Ingelheim in legal battle over Zantac liabilities

Fierce Pharma

When Sanofi made an asset swap with Boehringer Ingelheim in 2016, the French company acquired BI’s healthcare business, which included heartburn medicine Zantac. | In an asset swap with Boehringer in 2016, Sanofi gained U.S. marketing rights to the treatment.

Medicine 296
article thumbnail

Headspace Health advances equity of mental health through Shine acquisition

MedCity News

Shine was first created in 2016 to provide mental health support to those in marginalized communities. Acquiring Shine will help Headspace Health improve its diversity, equity, inclusion and belonging efforts.

289
289
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Pfizer settles gender pay discrimination allegations at NYC headquarters

Fierce Pharma

The accusations centered on the company's compensation of 86 female employees in 2015 and 2016. Department of Labor that it underpaid certain women who were employed at the company’s New York City headquarters. |

315
315
article thumbnail

National uninsured rate reaches record low at 8%, HHS report shows

MedCity News

The previous record for the lowest national uninsured rate was 9% in 2016. . million people have gained healthcare coverage since 2020.

article thumbnail

Merck pays Moderna $250M to share equally in cancer vaccine for melanoma

MedCity News

Moderna and Merck have been partners in the development of messenger RNA cancer vaccines since 2016. Merck is deepening the alliance by exercising an option that enables it to share equally in further work on a partnered cancer vaccine for melanoma.

Biopharma 290
article thumbnail

Pennsylvania pharmacy owner must pay $4M for “no questions asked” oxycodone sales

MedCity News

A neighborhood pharmacy owner was the largest purchaser of oxycodone among retail pharmacies in the entire state of Pennsylvania by 2016 and pled guilty to charges of conspiracy and fraud.

Retail 275
article thumbnail

Intercept's Ocaliva approval in jeopardy after FDA flags concerns in advisory committee briefing doc

Fierce Pharma

The regulator specifically raised an eyebrow at the post-marketing trials Intercept has used in a bid to keep hold of the accelerated approval it won back in 2016.

FDA 276